Harmony Biosciences Holdings, Inc. Revenue 2019–2025
Harmony Biosciences Holdings, Inc. reported $868.45M of revenue for fiscal 2025. That was 21.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +443.7%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $868.45M | +21.5% |
| FY 2024 | $714.73M | +22.8% |
| FY 2023 | $582.02M | +32.9% |
| FY 2022 | $437.86M | +43.4% |
| FY 2021 | $305.44M | +91.2% |
| FY 2020 | $159.74M | +2564.6% |
| FY 2019 | $6.00M | — |
Source: Harmony Biosciences Holdings, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HRMY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Harmony Biosciences Holdings, Inc. reported $868.45M of revenue for fiscal 2025. That was 21.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +443.7%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Harmony Biosciences Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHarmony Biosciences Holdings, Inc. — frequently asked questions
What is Harmony Biosciences Holdings, Inc.'s revenue?
Harmony Biosciences Holdings, Inc. (HRMY) reported revenue of $868.45M for fiscal year 2025, per its SEC filings.
How has Harmony Biosciences Holdings, Inc.'s revenue changed over time?
Between fiscal 2019 and 2025, HRMY's revenue grew at roughly 129.2% per year (compound annual rate), from $6.00M to $868.45M.
Where does this data come from?
Figures are computed from Harmony Biosciences Holdings, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.